CVS Health raises 2026 guidance after Q1 earnings beat
Key takeaways
- For the full year, CVS now targets adjusted earnings per share between $7.30 and $7.50, compared with previous guidance of $7.00 to $7.20.
- First-quarter revenue reached $100.4 billion, a 6.2% year-over-year increase, with CVS reporting adjusted earnings of $2.57 per share.
- With the results, CVS extended its run of topping Street expectations to five straight quarters, according to Reuters.
CVS Health raises 2026 guidance after Q1 earnings beat Quartz · Kevin Carter / Getty Images Cris Tolomia Wed, May 6, 2026 at 7:12 PM GMT+7 3 min read CVS CVS Health raised its full-year 2026 profit forecast on Wednesday after first-quarter results topped Wall Street estimates, driven by improved medical cost controls at its Aetna insurance unit.
For the full year, CVS now targets adjusted earnings per share between $7.30 and $7.50, compared with previous guidance of $7.00 to $7.20. Full-year revenue guidance was raised to at least $405 billion from at least $400 billion. Cash flow from operations guidance also increased to at least $9.5 billion from at least $9.0 billion.
First-quarter revenue reached $100.4 billion, a 6.2% year-over-year increase, with CVS reporting adjusted earnings of $2.57 per share. Wall Street had penciled in adjusted earnings of $2.20 per share and revenue of $95.09 billion, based on analyst surveys cited by CNBC.